tuberculosisdrugresearch.org - Institute for Tuberculosis Research

                                 On March 24, 1882 Robert Koch announced to the world his discovery of the causative agent of tuberculosis. More than 50 years passed before the first effective drug – streptomycin -  was discovered for this disease.  Over the next 25 years a number of additional drugs were discovered, forming the basis of our current TB drug regimen. Using these drugs requires 6 months of treatment for drug-sensitive TB and up to several years for multiple drug-resistant (MDR) or extensively drug resistant (XDR) TB. It has now been over 25 years since the introduction of the last drug developed primarily for use in TB – rifampin. Why? Read More..

   The Institute for Tuberculosis Research (ITR) is a university-based drug discovery research facility working on the development of new drugs to combat an old, but still evolving global public health threat. The Institute is unique in that it brings an industrial model of drug discovery into an academic environment. We have assembled all of the necessary components - medicinal chemistry, natural products chemistry, microbiology, drug metabolism and toxicology - under one roof to maximize efficiency and communication. In addition to in-house discovery projects, we also collaborate with many public and private sector institutions around the world to facilitate their efforts towards the same goal.       Read More..